Skip to main content
. 2022 Jul 31;29(1):2491–2497. doi: 10.1080/10717544.2022.2104406

Figure 4.

Figure 4.

(A) In vitro cytotoxic activities of PPM, PL-SNP and PL-Lip against HepG2 human cancer cells. (B) Confocal laser scanning microscopy (CLSM) images of HepG2 cells incubated with free coumarin-6, PL-SNP, or PL-Lip for 3 h.